September 20, 2014 9:29 PM ET

Pharmaceuticals

Company Overview of CROMA-PHARMA GmbH

Company Overview

CROMA-PHARMA GmbH develops, markets, and commercializes products in ophthalmology, osteoarthritis, and aesthetic dermatology fields. It offers eye drops and ointments for the treatment of dry eyes, medicinal products, intraocular lenses, viscoelastics, vitamac, vitreo-retinal products, and instruments and surgical devices. The company also provides food supplements for maintaining healthy joints and cartilages; coated tablets to support the body’s natural protection mechanisms against cartilage deterioration and preserve a healthy musculoskeletal system; biofermentativ produced hyaluronic acids to resemble the body’s own hyaluronic acid; and products for viscosupplementation therapy of large...

Industriezeile 6

Leobendorf,  2100

Austria

Founded in 1976

Phone:

43 22 62 684 68 0

Fax:

43 22 62 684 68 165

Key Executives for CROMA-PHARMA GmbH

Managing Director and Vice-President
Managing Director and Vice-President
Compensation as of Fiscal Year 2014.

CROMA-PHARMA GmbH Key Developments

Croma-Pharma Mulls IPO

Croma-Pharma Gmbh is considering an initial public offering (IPO) in 3-5 years, according to WirtschaftsBlatt which cited one of the owners, Andreas Prinz.

Croma-Pharma Gmbh Announces the Signing of Distribution Agreement with Hugel Inc

Croma-Pharma Gmbh announced the signing of a 10 year distribution agreement with Hugel Inc. CROMA-PHARMA will become the exclusive Distribution Partner and will be responsible for conducting the required clinical trials and studies. CROMA-PHARMA expects to invest an estimated two-digit million Euro amount for conducting these studies. Following the final approval of FDA, EMA and other authorities, CROMA-PHARMA will then market the new products in Europe, North America and Oceania markets. CROMA-PHARMA will promote the new products under their own brand. Products shall enter the markets in 2018. Forecast of sales until 2021 estimate returns of more than EUR 100 million in this dynamically growing market.

Croma-Pharma Gmbh Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013

Croma-Pharma Gmbh Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CROMA-PHARMA GmbH, please visit www.croma.at. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.